| PERIOD ENDING | 30-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 11,326 | 8,915 | 12,045 | 14,237 | | Cost of Revenue | 3,108 | 4,510 | 5,969 | 7,539 | | | Gross Profit | 2,230 | 4,405 | 6,076 | 6,698 | | | Operating Expenses | | Research Development | 2,354 | 1,896 | 2,545 | 3,219 | | Selling General and Administrative | 7,635 | 4,129 | 4,568 | 4,442 | | Non Recurring | 418 | (140) | 206 | 374 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,208) | (1,480) | (1,243) | (1,337) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46 | 391 | 118 | 274 | | Earnings Before Interest And Taxes | (7,162) | (1,089) | (1,125) | (1,063) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (7,162) | (1,089) | (1,125) | (1,063) | | Income Tax Expense | (80) | 198 | 97 | 211 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,082) | (1,287) | (1,222) | (1,274) | | | Non-recurring Events | | Discontinued Operations |
-
| (223) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,082) | (1,510) | (1,222) | (1,274) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,082) | ($1,510) | ($1,222) | ($1,274) |
|
0.51% Nasdaq 
Income Statement
